Annual Accounts Receivable
$60.59 M
+$4.66 M+8.33%
December 31, 2024
Summary
- As of March 10, 2025, CTKB annual accounts receivable is $60.59 million, with the most recent change of +$4.66 million (+8.33%) on December 31, 2024.
- During the last 3 years, CTKB annual accounts receivable has risen by +$30.83 million (+103.59%).
- CTKB annual accounts receivable is now at all-time high.
Performance
CTKB Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$60.59 M
+$7.95 M+15.11%
December 31, 2024
Summary
- As of March 10, 2025, CTKB quarterly accounts receivable is $60.59 million, with the most recent change of +$7.95 million (+15.11%) on December 31, 2024.
- Over the past year, CTKB quarterly accounts receivable has stayed the same.
- CTKB quarterly accounts receivable is now at all-time high.
Performance
CTKB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CTKB Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.3% | 0.0% |
| 3 y3 years | +103.6% | +22.1% |
| 5 y5 years | +253.3% | +22.1% |
CTKB Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +103.6% | at high | +103.6% |
| 5 y | 5-year | at high | +256.6% | at high | +301.6% |
| alltime | all time | at high | +256.6% | at high | +301.6% |
Cytek Biosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $60.59 M(+8.3%) | $60.59 M(+15.1%) |
| Sep 2024 | - | $52.63 M(+17.9%) |
| Jun 2024 | - | $44.64 M(-11.3%) |
| Mar 2024 | - | $50.31 M(-10.1%) |
| Dec 2023 | $55.93 M(+14.5%) | $55.93 M(+0.9%) |
| Sep 2023 | - | $55.40 M(+11.6%) |
| Jun 2023 | - | $49.62 M(+15.1%) |
| Mar 2023 | - | $43.10 M(-11.8%) |
| Dec 2022 | $48.86 M | $48.86 M(+23.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $39.64 M(+7.7%) |
| Jun 2022 | - | $36.81 M(+21.1%) |
| Mar 2022 | - | $30.41 M(+2.2%) |
| Dec 2021 | $29.76 M(+75.2%) | $29.76 M(+1.1%) |
| Sep 2021 | - | $29.45 M(+22.6%) |
| Jun 2021 | - | $24.03 M(+59.3%) |
| Mar 2021 | - | $15.09 M(-11.2%) |
| Dec 2020 | $16.99 M(-0.9%) | $16.99 M |
| Dec 2019 | $17.15 M | - |
FAQ
- What is Cytek Biosciences annual accounts receivable?
- What is the all time high annual accounts receivable for Cytek Biosciences?
- What is Cytek Biosciences annual accounts receivable year-on-year change?
- What is Cytek Biosciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cytek Biosciences?
- What is Cytek Biosciences quarterly accounts receivable year-on-year change?
What is Cytek Biosciences annual accounts receivable?
The current annual accounts receivable of CTKB is $60.59 M
What is the all time high annual accounts receivable for Cytek Biosciences?
Cytek Biosciences all-time high annual accounts receivable is $60.59 M
What is Cytek Biosciences annual accounts receivable year-on-year change?
Over the past year, CTKB annual accounts receivable has changed by +$4.66 M (+8.33%)
What is Cytek Biosciences quarterly accounts receivable?
The current quarterly accounts receivable of CTKB is $60.59 M
What is the all time high quarterly accounts receivable for Cytek Biosciences?
Cytek Biosciences all-time high quarterly accounts receivable is $60.59 M
What is Cytek Biosciences quarterly accounts receivable year-on-year change?
Over the past year, CTKB quarterly accounts receivable has changed by $0.00 (0.00%)